Transmembrane osmosis is one of the key parameters for recognizing Glycan-related Drugs. Drug efficacy depends on its ability to penetrate the cell membrane and metabolism level. Therefore, it is crucial to predict and analyze glycan-related drug transmembrane osmosis. By analyzing glycan-related drugs based on multiple dimensions (structural similarity, binding profiles, and network effects across pathways and molecular interaction maps), CD BioGlyco provides services including the analysis of drug transmembrane penetration mechanisms, analysis of drug penetration pathways, and prediction of targets of action.
Based on experienced researchers and reliable biological information (molecular fingerprinting fingerprints and computation of physicochemical descriptors with identification of graphical features), CD BioGlyco provides customized model construction services by different algorithms. We train computational models using different iterations, learning rates, and batch sizes to determine the optimal parameters and optimal models.
CD BioGlyco provides a full range of transmembrane osmosis parameter analysis services including permeate (i.e., size/shape, diffusivity, and hydrophobicity), membrane (i.e., size and lifetime of low-density areas on the membrane surface), free energy distribution analysis and calculation of the average time required for permeate to enter the membrane.
Based on algorithmic feature selection, molecular descriptors of atomic reactivity, bond strength, and physicochemical properties, our researchers provide transmembrane site prediction services. In predictive modeling, we also provide glycan-related drug metabolic pathway analysis services.
Our lab analyzes a variety of permeabilities such as apparent permeability, cellular bypass permeability, and transcellular membrane permeability. Our professional staff provides visualization of reactivity scores for possible reaction sites.
Based on pharmacokinetic information and specific information (shaking rate, pH, cell cycle, volume of the drug solution, etc.) of glycan-related drugs, we offer a rapid analysis service of concentration and permeability at different sites during transmembrane absorption.
Technology: Machine learning (ML), Graph neural network (GNN)
Journal: Journal of Cheminformatics
Published: 2022
IF: 8.6
Results: Combining ML and GNN approaches, researchers developed a new computational framework, Meta UDP-glucuronosyltransferases (Meta-UGTs), for predicting the UGT-mediated metabolism of drug molecules. The predictive performance and stability of the model were improved through training, optimization, and evaluation. Our model accurately predicts the sites where glucuronidation reactions occur. As the amount of data increases, the accuracy of the deep-learning model improves. Meta-UGT provides rational guidance for UGT-mediated drug metabolism and transmembrane analysis.
Fig.1 Ten-fold cross-validation of substrate-based prediction models. (Huang, et al., 2022)
CD BioGlyco has a well-trained team and advanced computers to provide clients with satisfactory transmembrane osmosis analysis. We always maintain a passionate and professional philosophy to serve every client. Please feel free to contact us.
References
We envision a future where the intricate world of carbohydrate is no longer shrouded in mystery, but rather illuminated by the power of cutting-edge computational tools.